relative to increasing transparency in the 340B Drug Pricing Program.

Latest action: Refer to Interim Study, MA, VV; 03/05/2026; SJ 5

Voted 3/5/2026View source

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

3/5/2026Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
2/19/2026SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4
2/19/2026Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4
2/19/2026Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8
2/12/2026Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6
1/12/2026Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2
11/21/2025Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1